clarinex d 24 hour Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clarinex D 24 Hour, and what generic alternatives are available?
Clarinex D 24 Hour is a drug marketed by Organon and is included in one NDA.
The generic ingredient in CLARINEX D 24 HOUR is desloratadine; pseudoephedrine sulfate. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for clarinex d 24 hour?
- What are the global sales for clarinex d 24 hour?
- What is Average Wholesale Price for clarinex d 24 hour?
Summary for clarinex d 24 hour
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 19 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | clarinex d 24 hour at DailyMed |
![clarinex d 24 hour drug patent expirations Drug patent expirations by year for clarinex d 24 hour](/p/graph/s/t/clarinex_d_24_hour-patent-expirations.png)
Recent Clinical Trials for clarinex d 24 hour
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
J. Uriach and Company | Phase 1 |
Derm Research, PLLC | Phase 4 |
UCB Pharma | Phase 4 |
US Patents and Regulatory Information for clarinex d 24 hour
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | CLARINEX D 24 HOUR | desloratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 021605-001 | Mar 3, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for clarinex d 24 hour
International Patents for clarinex d 24 hour
See the table below for patents covering clarinex d 24 hour around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 8603532 | ⤷ Sign Up | |
China | 1211079 | ⤷ Sign Up | |
Saudi Arabia | 01210740 | تركيب على شكل جرعات تؤخذ عن طريق الفم ممتدة الانطلاق. (Extended release oral dosage composition.) | ⤷ Sign Up |
Saudi Arabia | 01210741 | تركيب ثابت على شكل جرعات عن طريق الفم ممتدة الانطلاق. (Stable extended release oral dosage composition.) | ⤷ Sign Up |
Norway | 331645 | ⤷ Sign Up | |
New Zealand | 300398 | Pharmaceutical uses of the pyridine derivative descarboethoxyloratadine (DCL) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for clarinex d 24 hour
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0152897 | C00152897/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH |
1110543 | SPC063/2007 | Ireland | ⤷ Sign Up | SPC063/2007: 20081105, EXPIRES: 20220729 |
0152897 | 2001C/013 | Belgium | ⤷ Sign Up | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
1110543 | SZ 1/2008 | Austria | ⤷ Sign Up | PRODUCT NAME: DESLORATADIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, KOMBINIERT MIT PSEUDOEPHEDRIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER ESTERS |
1110543 | 122008000001 | Germany | ⤷ Sign Up | PRODUCT NAME: DESLORATADIN MIT PSEUDOEPHEDRIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ VON PSEUDOEPHEDRIN; REGISTRATION NO/DATE: EU/1/07/399/001-006 20070730 |
1110543 | CA 2008 00010 | Denmark | ⤷ Sign Up | PRODUCT NAME: KOMBINATION OMFATTENDE DESLORATADIN OG PSEUDOEPHEDRIN, EVENTUELT I FORM AF ET FYSIOLOGISK ACCEPTABELT SALT IFOELGE NEDENSTAENDE GRUNDPATENT, HERUNDER PSEUDOEPHEDRIN SOM SULFAT |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |